{"AllianceGenome": "11701", "HGNC": "11701", "MIM": "187395", "_id": "6997", "_version": 1, "accession": {"genomic": ["AC104304.2", "CH471055.1", "CP068275.2", "M96955.1", "NC_000003.12", "NC_060927.1", "NG_017049.1", "NG_021214.1"], "protein": ["AAA61134.1", "AAH22393.1", "AAH67844.1", "BAG36124.1", "CAA32467.1", "EAW64773.1", "EAW64774.1", "NP_001167607.1", "NP_003203.1", "P13385.1"], "rna": ["AK313319.1", "AU125451.1", "BC022393.1", "BC067844.1", "CX755454.1", "CX781482.1", "CX785985.1", "DA941183.1", "NM_001174136.2", "NM_003212.4", "X14253.1"], "translation": [{"protein": "AAH22393.1", "rna": "BC022393.1"}, {"protein": "CAA32467.1", "rna": "X14253.1"}, {"protein": "AAH67844.1", "rna": "BC067844.1"}, {"protein": "NP_001167607.1", "rna": "NM_001174136.2"}, {"protein": "BAG36124.1", "rna": "AK313319.1"}, {"protein": "NP_003203.1", "rna": "NM_003212.4"}]}, "alias": ["CR", "CR-1", "CRGF", "TDGF1"], "ensembl": {"gene": "ENSG00000241186", "protein": ["ENSP00000296145", "ENSP00000446375"], "transcript": ["ENST00000296145", "ENST00000459867", "ENST00000471721", "ENST00000493282", "ENST00000542931"], "translation": [{"protein": "ENSP00000446375", "rna": "ENST00000542931"}, {"protein": "ENSP00000296145", "rna": "ENST00000296145"}], "type_of_gene": "protein_coding"}, "entrezgene": "6997", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 7.44039374, "exp_mis": 79.3311195, "exp_syn": 30.679829, "lof_z": -0.203223677552653, "mis_z": 0.347676395676624, "mu_lof": 4.34750637358e-07, "mu_mis": 6.77979940383e-06, "mu_syn": 2.48585475035e-06, "n_lof": 8.0, "n_mis": 73.0, "n_syn": 36.0, "p_li": 3.98298058552725e-06, "p_null": 0.787247875034508, "p_rec": 0.212748141984906, "syn_z": -0.595454374238172}, "bp": 567, "cds_end": 46622740, "cds_start": 46619459, "n_exons": 6, "nonpsych": {"exp_lof": 6.6104607, "exp_mis": 71.678507, "exp_syn": 27.6443936, "lof_z": -0.148794680028354, "mis_z": 0.397875116143894, "mu_lof": 4.34750637358e-07, "mu_mis": 6.77979940383e-06, "mu_syn": 2.48585475035e-06, "n_lof": 7.0, "n_mis": 65.0, "n_syn": 31.0, "p_li": 2.2192908286355e-05, "p_null": 0.728612626110497, "p_rec": 0.271365180981217, "syn_z": -0.401819927689375}, "nontcga": {"exp_lof": 6.83309377, "exp_mis": 72.9725666, "exp_syn": 28.21337651, "lof_z": -0.0629861563841536, "mis_z": 0.23168676793708, "mu_lof": 4.34750637358e-07, "mu_mis": 6.77979940383e-06, "mu_syn": 2.48585475035e-06, "n_lof": 7.0, "n_mis": 69.0, "n_syn": 30.0, "p_li": 2.4990799479045e-05, "p_null": 0.690811892623628, "p_rec": 0.309163116576893, "syn_z": -0.2129741683274}, "transcript": "ENST00000296145.5"}, "exons": [{"cdsend": 46581250, "cdsstart": 46579107, "chr": "3", "position": [[46574534, 46574583], [46579094, 46579147], [46579231, 46579366], [46579738, 46579853], [46579950, 46580060], [46581131, 46582457]], "strand": 1, "transcript": "NM_001174136", "txend": 46582457, "txstart": 46574534}, {"cdsend": 46581250, "cdsstart": 46577969, "chr": "3", "position": [[46577787, 46578004], [46579094, 46579147], [46579231, 46579366], [46579738, 46579853], [46579950, 46580060], [46581131, 46582457]], "strand": 1, "transcript": "NM_003212", "txend": 46582457, "txstart": 46577787}], "exons_hg19": [{"cdsend": 46622740, "cdsstart": 46620597, "chr": "3", "position": [[46616024, 46616073], [46620584, 46620637], [46620721, 46620856], [46621228, 46621343], [46621440, 46621550], [46622621, 46623947]], "strand": 1, "transcript": "NM_001174136", "txend": 46623947, "txstart": 46616024}, {"cdsend": 46622740, "cdsstart": 46619459, "chr": "3", "position": [[46619277, 46619494], [46620584, 46620637], [46620721, 46620856], [46621228, 46621343], [46621440, 46621550], [46622621, 46623947]], "strand": 1, "transcript": "NM_003212", "txend": 46623947, "txstart": 46619277}], "generif": [{"pubmed": 12052855, "text": "Cripto has dual roles as a coreceptor as well as a coligand for Nodal and that this signaling interaction with Nodal is regulated by an unusual form of glycosylation."}, {"pubmed": 12073012, "text": "A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects."}, {"pubmed": 12682303, "text": "complexation with activin and type II activin receptors and role in blocking activin signaling"}, {"pubmed": 14581455, "text": "CRIPTO signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells."}, {"pubmed": 14584041, "text": "Results suggest that cripto-1 overexpression might be associated with the progression towards a more aggressive phenotype in breast carcinoma, through the activation of both Akt and Smad-2 signalling pathways."}, {"pubmed": 16176936, "text": "The regulation of Netrin-1 expression is important in regulating Cripto-1-dependent invasion and migration of mammary epithelial cells."}, {"pubmed": 16951234, "text": "The plasma CR-1 might represent a novel biomarker for the detection of breast and colon carcinomas. A statistically significant increase in the levels of plasma CR-1 was found in patients with colon carcinoma and in patients with breast carcinoma."}, {"pubmed": 16954206, "text": "CRIPTO-3, a processed pseudogene of CRIPTO-1 on the X chromosome, is expressed in undifferentiated NT2 cells and is regulated by germ cell nuclear factor in parallel to CRIPTO-1"}, {"pubmed": 17030617, "text": "Cripto inhibits the tumor suppressor function of TGF-beta by a novel mechanism."}, {"pubmed": 17291450, "text": "Transcriptional regulation of CR-1 expression by WNT signaling through an intronic-exonic enhancer element, containing three tandem TCF/LEF binding sites within the CR-1 gene."}, {"pubmed": 17720976, "text": "Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration are reported."}, {"pubmed": 17925387, "text": "GPI attachment of CR-1 is required for the paracrine activity as a Nodal co-receptor."}, {"pubmed": 17941089, "text": "Tese results suggest a differential modulation of CR-1 gene expression in embryonal and colon cancer cells by two different members of the TGF-beta family."}, {"pubmed": 18089557, "text": "Cripto facilitates Nodal signaling and inhibits activin signaling by forming receptor complexes with these ligands that are structurally and functionally similar."}, {"pubmed": 18312357, "text": "Combined analysis of Cripto-1 and E-cadherin has significant value in evaluating the metastatic potential of gastric cancer and predicting patient prognosis."}, {"pubmed": 19035567, "text": "Study indicate that the synthetic h-CFC interacts with the ALK4 receptor with a K(D) in micro M range, that the h-CFC overall topology is determined by the presence of three disulfide bridges."}, {"pubmed": 19082438, "text": "Cripto-1 overexpression is involved in the tumorigenesis of gastric- and pancreatobiliary-type intraductal papillary mucinous neoplasms"}, {"pubmed": 19386982, "text": "Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosis."}, {"pubmed": 19421146, "text": "Results show that targeted disruption of the cell surface Cripto/GRP78 complex precludes Cripto activation of MAPK/PI3K and Smad2/3 pathways."}, {"pubmed": 19727905, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19732464, "text": "Cripto-1 overexpression is connected with the tumorigenesis and progression of nasopharyngeal carcinoma."}, {"pubmed": 19853938, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19853938, "text": "work firstly provides human genetic evidence of TDGF1 involved in the pathogenesis of ventricular septal defects"}, {"pubmed": 19874624, "text": "Nodal and Cripto immunoreactivity increased dramatically in the transition from histologic Grade 1 to histologic Grades 2 and 3 endometrial carcinomas."}, {"pubmed": 20126975, "text": "TDGF1 has a role in metachronous metastasis of colorectal cancer"}, {"pubmed": 20128024, "text": "Data suggest that the up-regulation of CR-1 and p-STAT3 may play important roles in gastric carcinogenesis and lymph node metastasis"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20385969, "text": "TDGF-1, which is significantly upregulated in APA and mediates aldosterone hypersecretion and deregulated growth in adrenocortical cells in vitro, may represent a key player in the development and pathophysiology of primary aldosteronism."}, {"pubmed": 20549704, "text": "Results demonstrate that CR-1 expression is enriched in an undifferentiated, tumorigenic subpopulation and is regulated by key regulators of pluripotent stem cells."}, {"pubmed": 20629020, "text": "molecular model of activin receptor-like kinase 4/Cripto/Nodal complex built by homology modeling as well as docking tests aimed at identifying potential binding epitopes"}, {"pubmed": 21055389, "text": "expression of CR-1 may alter the physiochemical properties of the plasma membrane resulting in an enhancement of intercellular transfer of cellular signaling components which may account for the paracrine activity of CR-1."}, {"pubmed": 21496809, "text": "Disturbed expression of endometrial activin A, cripto , and follistatin suggests a dysfunction of the activin pathway in endometriosis/endometrioma."}, {"pubmed": 21824804, "text": "Cripto-1 plays a role in the malignant transformation of oral mucosa and is involved in the tumorigenesis and progression of oral squamous cell carcinoma by promoting the growth and migration of malignant cells."}, {"pubmed": 21863025, "text": "High CRIPTO-1 is associated with cutaneous melanoma."}, {"pubmed": 22306319, "text": "Cripto/GRP78 modulates the TGF-beta pathway in development and oncogenesis [review]"}, {"pubmed": 22542493, "text": "Cripto-1 may play a role during developmental EMT, and it may also be involved in the reprogramming of differentiated tumor cells into cancer stem cells through the induction of an EMT program."}, {"pubmed": 23022962, "text": "Cross-talk between Cripto-1 and the Wnt/beta-catenin signaling pathway might play a role in mammary transformation leading to a more aggressive behavior of mammary cancer cells."}, {"pubmed": 23034635, "text": "human testicular tumors showed upregulation of NODAL and CRIPTO that was proportional to invasiveness and to the number of malignant cells."}, {"pubmed": 23129342, "text": "Offer some insight into the transcriptional regulation of CR-1 gene expression and its critical role in the pathogenesis of human cancer."}, {"pubmed": 23574716, "text": "The significance of cell surface CR-1 expression in human melanoma cells, was examined."}, {"pubmed": 24379580, "text": "Cripto is overexpressed in colonic neoplasms and is related to cancer cell migration/invasion."}, {"pubmed": 24500260, "text": "These findings clearly suggest that the downregulation of miR-15a-16 with Cripto amplification may be involved in the development of nonsmall cell lung cancer."}, {"pubmed": 24521322, "text": "CR-1 expression in glioblastoma multiforme(GBM)tissue and blood; CR-1 plasma levels from GBM patients were elevated compared with normal; CR-1 concentrations higher than normal correlated with shorter overall survival; identified CR-1 in different areas of GBM tissue including perivascular tumor cells and endothelial cells"}, {"pubmed": 24749068, "text": "these findings identify the CRIPTO/GRP78 pathway as a developmentally conserved regulator of fetal and adult mammary stem cell behavior ex vivo, with implications for the stem-like cells found in many cancers."}, {"pubmed": 24870591, "text": "Data suggest that the high expression of Cripto-1 (CR-1) may play an important role in the progression of non-small cell lung cancer (NSCLC), and CR-1 expression may offer a valuable marker for predicting the outcome of patients with NSCLC."}, {"pubmed": 24911146, "text": "Tumors from NSCLC patients with EGFR-activating mutations that were intrinsically resistant to EGFR-TKIs expressed higher levels of CRIPTO1 compared with tumors from patients that were sensitive to EGFR-TKIs."}, {"pubmed": 25165718, "text": "This study demonstrated CR-1 expression in the placental bed, its increased expression in creta placentas, and EVT cells as the main CR-1-producing cell type."}, {"pubmed": 25228630, "text": "Report lower gene expression of Cripto in endometriosis but difference not maintained at protein level."}, {"pubmed": 25326807, "text": "Our findings suggest that high Cripto-1 expression might be involved in the development of bladder cancer and a potentially effective prognostic marker in bladder cancer patients"}, {"pubmed": 25596738, "text": "these findings suggest a novel molecular network, involving CRIPTO, AKT, and FGFR signaling, in favor of the emergence of mesenchymal-like cancer cells during the development of aggressive prostate tumors."}, {"pubmed": 25629528, "text": "the functional analysis of the main associated locus identified a causal variant in the 5'UTR of CRIPTO gene which is able to strongly modulate CRIPTO expression through an AP-1-mediate transcriptional regulation."}, {"pubmed": 25658584, "text": "Treatment of U-87 MG cells with CR-1 leads to higher expression of drug efflux protein MDR-1 in the CR-1 positive subpopulation, indicating correlated induction of these two proteins."}, {"pubmed": 25796148, "text": "Over expression of Cripto-1 was correlated with the occurrence, development, metastasis and malignant degree of lung adenocarcinoma."}, {"pubmed": 25889638, "text": "Snail represses Cripto-1 gene by direct transcriptional interaction"}, {"pubmed": 26109366, "text": "serum CR-1 is a useful diagnostic and prognostic marker for nonsmall cell lung cancer patients."}, {"pubmed": 26327334, "text": "The main signaling pathways mediating Cripto-1 effects include Nodal-dependent (Smad2/3) and Nodal-independent (Src/p44/42/Akt) signaling transduction pathways"}, {"pubmed": 26343543, "text": "Cripto-1 is a novel and dynamically regulated effector of stem cell functions in colorectal cancer."}, {"pubmed": 26375669, "text": "Cripto-1 overexpression contributes to aggressiveness and poor prognosis of hepatocellular carcinoma"}, {"pubmed": 26654129, "text": "These findings suggest that CRIPTO expression may be a useful serological marker for diagnostic and/or prognostic purposes during germ cell cancer management."}, {"pubmed": 27082313, "text": "the miR-15b expression is negatively associated with the cripto-1 expression in glioma cells. miR-15b may subsequently impair growth and invasion of glioma cells through targeted regulation of cripto-1."}, {"pubmed": 27881714, "text": "PGAP6 plays a critical role in Nodal signaling modulation through CRIPTO shedding."}, {"pubmed": 28098905, "text": "Upregulation of cripto-1 is associated with prostate cancer."}, {"pubmed": 28394345, "text": "These results highlight a functional role for CRIPTO and GRP78 in prostate cancer metastasis and suggest that targeting CRIPTO/GRP78 signaling may have significant therapeutic potential."}, {"pubmed": 28431580, "text": "Results identified elevated CR-1 expression in esophageal squamous cell carcinoma (ESCC) specimens which correlated to poor prognosis of the patients. CR-1 high cells isolated from ESCC cells possess cancer stem-like cells (ECSLC) properties."}, {"pubmed": 29223130, "text": "Cripto-1 expression is increased by OCT4 overexpression, but decreased by shRNA-mediated OCT4 knockdown. OCT4 overexpression significantly activates Cripto-1 transcriptional activity. A 5'-upstream minimal promoter sequence in the gene-encoding Cripto-1 is significantly activated by OCT4 overexpression."}, {"pubmed": 29226519, "text": "Using molecular dynamics simulations, study demonstrated that Cripto binding to GRP78 completely changes the dynamics of its behavior on the membrane, not allowing GRP78 to disconnect from it, thus enabling GRP78 tumorigenic functions."}, {"pubmed": 29358554, "text": "Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells."}, {"pubmed": 29413049, "text": "CR-1 expression was evaluated with immunohistochemistry using a tissue microarray on 265 T1-2N0 surgical NSCLC samples. Of the 265 tumors, 250 (94%) expressed various levels of CR-1."}, {"pubmed": 29445127, "text": "Cripto-1 knockdown in vitro and in vivo were partially rescued by forced expression of constitutively active beta-catenin. Further elucidation revealed the binding of Cripto-1 to Frizzled-7 (FZD7), low-density lipoprotein receptor-related protein 6 (LRP6) and Dishevelled-3 (DVL3) of the Wnt/beta-catenin pathway and stabilized DVL3 protein."}, {"pubmed": 29604056, "text": "CRIPTO signalling promotes an aggressive tumor phenotype and resistance to sorafenib treatment in hepatocellular carcinoma."}, {"pubmed": 29807222, "text": "Targeting the Cripto-1/TAK-1/NF-kappaB/Survivin pathway may be an effective approach to combat apoptosis resistance in cancer."}, {"pubmed": 29882484, "text": "we report for the first time that Cripto-1 protein (teratocarcinoma-derived growth factor 1, epidermal growth factor-Cripto/FRL-1/Cryptic) produced by human embryonic stem cells (hESC) represents a factor capable of inducing formation of supernumerary centrosomes in cultured hESC"}, {"pubmed": 30373174, "text": "This study has successfully demonstrated that exogenous soluble form of CR-1 suppresses the self-renewal of cancer stem cells."}, {"pubmed": 30860275, "text": "Investigated teratocarcinoma-derived growth factor 1 (Cripto-1) expression in placentas of women with placenta accreta and placenta previa. Found the level of placental Cripto-1 in placenta increta was higher than placenta accrete, and both were higher than healthy controls."}, {"pubmed": 31136302, "text": "expression correlated with epithelial-mesenchymal transition"}, {"pubmed": 31295488, "text": "oxidative refolding mechanism of Cripto-1 CFC domain"}, {"pubmed": 31455359, "text": "CR-1 expression was elevated in ccRCC tumor tissues and serum samples. CR-1 expression was correlated with aggressive tumor phenotype and poor survival."}, {"pubmed": 31543278, "text": "The results connect the refined subcellular localization of cripto-1 to its functions in cellular orientation and migration."}, {"pubmed": 31692030, "text": "KRAS mutation and abnormal expression of Cripto-1 as two potential candidate biomarkers for detection of colorectal cancer development."}, {"pubmed": 32134335, "text": "Prognostic value of cripto-1 expression in non-small-cell lung cancer patients: a systematic review and meta-analysis."}, {"pubmed": 32157913, "text": "Cripto-1 was positive in 68 out of 192 cases (35%) of colorectal cancer by immunohistochemistry. Cripto-1 expression was correlated with worse prognosis and was an independent prognostic factor. Cripto-1-silenced colorectal cancer cell lines had reduced cell proliferation, migration, and activation of Akt and MAPK signaling pathways in vitro, and decreased tumor growth and lymph node metastasis in vivo."}, {"pubmed": 32648918, "text": "Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma."}, {"pubmed": 32649753, "text": "Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma."}, {"pubmed": 33144398, "text": "E2A regulates neural ectoderm fate specification in human embryonic stem cells."}, {"pubmed": 33966694, "text": "[Expression and Prognostic Value of Cripto-1 in Pancreatic Cancer]."}, {"pubmed": 34357595, "text": "Cripto favors chondrocyte hypertrophy via TGF-beta SMAD1/5 signaling during development of osteoarthritis."}, {"pubmed": 34502188, "text": "Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells."}, {"pubmed": 34517344, "text": "Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways."}, {"pubmed": 34569498, "text": "miR-3929 Inhibits Proliferation and Promotes Apoptosis by Downregulating Cripto-1 Expression in Cervical Cancer Cells."}, {"pubmed": 34943832, "text": "Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis."}, {"pubmed": 35434129, "text": "CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies."}], "genomic_pos": {"chr": "3", "end": 46582457, "ensemblgene": "ENSG00000241186", "start": 46574534, "strand": 1}, "genomic_pos_hg19": {"chr": "3", "end": 46668033, "start": 46616045, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0001568", "qualifier": "involved_in", "term": "blood vessel development"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0001763", "pubmed": 10070255, "qualifier": "involved_in", "term": "morphogenesis of a branching structure"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0002042", "pubmed": 17720976, "qualifier": "involved_in", "term": "cell migration involved in sprouting angiogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007173", "pubmed": 8006041, "qualifier": "NOT acts_upstream_of_or_within", "term": "epidermal growth factor receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007368", "qualifier": "involved_in", "term": "determination of left/right symmetry"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007507", "qualifier": "involved_in", "term": "heart development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007507", "pubmed": 9576836, "qualifier": "involved_in", "term": "heart development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008284", "pubmed": 8006041, "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of cell population proliferation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0008284", "pubmed": 11857442, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0008595", "qualifier": "involved_in", "term": "anterior/posterior axis specification, embryo"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0009792", "pubmed": 11857442, "qualifier": "involved_in", "term": "embryo development ending in birth or egg hatching"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009952", "qualifier": "involved_in", "term": "anterior/posterior pattern specification"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009966", "pubmed": 12649175, "qualifier": "involved_in", "term": "regulation of signal transduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010595", "pubmed": 17720976, "qualifier": "involved_in", "term": "positive regulation of endothelial cell migration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0018105", "pubmed": 10493495, "qualifier": "involved_in", "term": "peptidyl-serine phosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0030154", "pubmed": 11857442, "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030335", "pubmed": 12649175, "qualifier": "involved_in", "term": "positive regulation of cell migration"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0030879", "pubmed": 11857442, "qualifier": "involved_in", "term": "mammary gland development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035729", "pubmed": 17720976, "qualifier": "involved_in", "term": "cellular response to hepatocyte growth factor stimulus"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0038092", "qualifier": "involved_in", "term": "nodal signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043066", "pubmed": 10493495, "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043406", "pubmed": 9013573, "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of MAP kinase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043410", "pubmed": 9013573, "qualifier": "involved_in", "term": "positive regulation of MAPK cascade"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0044344", "pubmed": 17720976, "qualifier": "involved_in", "term": "cellular response to fibroblast growth factor stimulus"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0050731", "pubmed": 10493495, "qualifier": "involved_in", "term": "positive regulation of peptidyl-tyrosine phosphorylation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071346", "pubmed": 17720976, "qualifier": "involved_in", "term": "cellular response to type II interferon"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071354", "pubmed": 17720976, "qualifier": "involved_in", "term": "cellular response to interleukin-6"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071356", "pubmed": 17720976, "qualifier": "involved_in", "term": "cellular response to tumor necrosis factor"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071364", "pubmed": 17720976, "qualifier": "involved_in", "term": "cellular response to epidermal growth factor stimulus"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005576", "qualifier": "is_active_in", "term": "extracellular region"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 17720976, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0009986", "qualifier": "is_active_in", "term": "cell surface"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 12925698, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016324", "pubmed": 17720976, "qualifier": "located_in", "term": "apical plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0019897", "qualifier": "located_in", "term": "extrinsic component of plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0045121", "pubmed": 17720976, "qualifier": "located_in", "term": "membrane raft"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098552", "qualifier": "located_in", "term": "side of membrane"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0005102", "pubmed": 11909953, "qualifier": "enables", "term": "signaling receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 12919325, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008083", "pubmed": [8006041, 12925698], "qualifier": "enables", "term": "growth factor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0038100", "qualifier": "enables", "term": "nodal binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0070697", "qualifier": "enables", "term": "activin receptor binding"}]}, "homologene": {"genes": [[8364, 100038139], [9544, 712918], [9598, 740372], [9606, 6997], [9615, 482156], [9913, 784029], [9913, 101906048], [10090, 21667], [10116, 680246]], "id": 2416}, "interpro": [{"desc": "EGF-like domain", "id": "IPR000742", "short_desc": "EGF-like_dom"}, {"desc": "Teratocarcinoma-derived growth factor Cripto", "id": "IPR017047", "short_desc": "Cripto_growth_factor"}, {"desc": "Cryptic/Cripto, CFC domain", "id": "IPR019011", "short_desc": "Cryptic/Cripto_CFC-dom"}], "ipi": ["IPI00008499", "IPI00956535"], "map_location": "3p21.31", "name": "cripto, EGF-CFC family member", "other_names": ["cripto-1 growth factor", "epidermal growth factor-like cripto protein CR1", "protein Cripto", "teratocarcinoma-derived growth factor 1"], "pantherdb": {"HGNC": "11701", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "98658", "ortholog_type": "LDO", "panther_family": "PTHR14949", "taxid": 10090, "uniprot_kb": "P51865"}, {"RGD": "1594185", "ortholog_type": "LDO", "panther_family": "PTHR14949", "taxid": 10116, "uniprot_kb": "F1M2P2"}, {"Ensembl": "ENSGALG00000012623", "ortholog_type": "O", "panther_family": "PTHR14949", "taxid": 9031, "uniprot_kb": "Q9I8Q3"}, {"ZFIN": "ZDB-GENE-990415-198", "ortholog_type": "O", "panther_family": "PTHR14949", "taxid": 7955, "uniprot_kb": "F1Q691"}, {"FlyBase": "FBgn0035539", "ortholog_type": "O", "panther_family": "PTHR14949", "taxid": 7227, "uniprot_kb": "Q95RQ1"}, {"FlyBase": "FBgn0003390", "ortholog_type": "O", "panther_family": "PTHR14949", "taxid": 7227, "uniprot_kb": "Q9W3W5"}, {"dictyBase": "DDB_G0281843", "ortholog_type": "O", "panther_family": "PTHR14949", "taxid": 352472, "uniprot_kb": "Q54TD6"}, {"Gene_ORFName": "DDB0186573", "ortholog_type": "O", "panther_family": "PTHR14949", "taxid": 352472, "uniprot_kb": "Q54N14"}], "uniprot_kb": "P13385"}, "pathway": {"pid": {"id": "glypican_1pathway", "name": "Glypican 1 network"}, "reactome": [{"id": "R-HSA-1181150", "name": "Signaling by NODAL"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1433617", "name": "Regulation of signaling by NODAL"}, {"id": "R-HSA-2892247", "name": "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"}, {"id": "R-HSA-452723", "name": "Transcriptional regulation of pluripotent stem cells"}]}, "pfam": "PF09443", "pharmgkb": "PA36420", "pharos": {"target_id": 7743, "tdl": "Tbio"}, "pir": "B39787", "prosite": "PS50026", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF326197", "relationship": "is"}, {"id": "GNF326198", "relationship": "is"}, {"id": "GNF326199", "relationship": "is"}], "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF220290", "relationship": "similar to"}, {"id": "GNF257095", "relationship": "is"}, {"id": "GNF257096", "relationship": "is"}, {"id": "GNF257097", "relationship": "is"}, {"id": "GNF257098", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF091378", "relationship": "is"}, {"id": "GNF091379", "relationship": "is"}, {"id": "GNF091380", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052567", "relationship": "is"}, {"id": "GNF057336", "relationship": "is"}, {"id": "GNF072395", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070405", "relationship": "is"}, {"id": "GNF070406", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF014421", "relationship": "is"}, {"id": "GNF014422", "relationship": "is"}], "MasterSecretomicsList": [{"id": "GNF330619", "relationship": "is"}, {"id": "GNF331856", "relationship": "is"}, {"id": "GNF333643", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF108973", "relationship": "is"}, {"id": "GNF148614", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1", "NG_017049.1", "NG_021214.1"], "protein": ["NP_001167607.1", "NP_003203.1"], "rna": ["NM_001174136.2", "NM_003212.4"], "translation": [{"protein": "NP_001167607.1", "rna": "NM_001174136.2"}, {"protein": "NP_003203.1", "rna": "NM_003212.4"}]}, "reporter": {"HG-U133_Plus_2": "206286_s_at", "HG-U95Av2": "40386_r_at", "HTA-2_0": ["TC03003403.hg.1", "TC03003404.hg.1"], "HuEx-1_0": ["2620937", "2620964", "3833154"], "HuGene-1_1": "8079422", "HuGene-2_1": "16940225"}, "summary": "This gene encodes an epidermal growth factor-related protein that contains a cripto, FRL-1, and cryptic domain. The encoded protein is an extracellular, membrane-bound signaling protein that plays an essential role in embryonic development and tumor growth. Mutations in this gene are associated with forebrain defects. Pseudogenes of this gene are found on chromosomes 2, 3, 6, 8, 19 and X. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010].", "symbol": "CRIPTO", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420667"}, "unigene": "Hs.385870", "uniprot": {"Swiss-Prot": "P13385", "TrEMBL": "F5H1T8"}, "wikipedia": {"url_stub": "Teratocarcinoma-derived growth factor 1"}}